| Sources | Names Used |
|---|---|
| CTRPv2 | BRD-K34485477 |
| PharmacoGx | BRD-K34485477 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CCDC136 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.04 |
| mRNA | MID2 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.04 |
| mRNA | ARMCX6 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.04 |
| mRNA | RANBP9 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.04 |
| mRNA | CCDC51 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.04 |
| mRNA | AGTR1 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.04 |
| mRNA | LAMTOR3 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.04 |
| mRNA | CD96 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.04 |
| mRNA | MCPH1 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.04 |
| mRNA | POU4F1 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.04 |
